Filing Details
TuHURA Biosciences, Inc./NV (NASDAQ:HURA) filed a Form 8-K with the Securities and Exchange Commission on July 07, 2026, disclosing a material event.
8k filedNASDAQ:HURA
TuHURA Biosciences, Inc./NV (HURA) Reports Material Event to SEC
Filing Details TuHURA Biosciences, Inc./NV (NASDAQ:HURA) filed a Form 8-K with the Securities and Exchange Commission on July 07, 2026, disclosing a material event. Market Context…
Market Context
TuHURA Biosciences, Inc./NV's stock currently trades at $2.24 with a market capitalization of $52.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for TuHURA Biosciences, Inc./NV's stock.
All SEC filings for TuHURA Biosciences, Inc./NV are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HURA Stock Page
Frequently Asked Questions
Where can I read HURA's SEC filings?
Browse all filings on our HURA SEC filings page.
What types of SEC filings does TuHURA Biosciences, Inc./NV file?
Public companies like TuHURA Biosciences, Inc./NV file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.